BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 17692499)

  • 1. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
    Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
    Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
    Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
    Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
    Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
    Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
    Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb.
    Rokutanda T; Izumiya Y; Miura M; Fukuda S; Shimada K; Izumi Y; Nakamura Y; Araki S; Hanatani S; Matsubara J; Nakamura T; Kataoka K; Yasuda O; Kaikita K; Sugiyama S; Kim-Mitsuyama S; Yoshikawa J; Fujita M; Yoshiyama M; Ogawa H
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2872-80. PubMed ID: 21940947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase.
    Izumi Y; Shiota M; Kusakabe H; Hikita Y; Nakao T; Nakamura Y; Muro T; Miura K; Yoshiyama M; Iwao H
    Hypertens Res; 2009 Aug; 32(8):675-9. PubMed ID: 19498441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
    Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
    Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
    Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
    Howarth AG; Wiehler WB; Pannirselvam M; Jiang Y; Berger JP; Severson D; Anderson TJ; Triggle CR
    J Pharmacol Exp Ther; 2006 Jan; 316(1):364-70. PubMed ID: 16249369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
    Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol stimulates revascularisation in response to ischaemia via an eNOS-dependent mechanism.
    Hori A; Shibata R; Morisaki K; Murohara T; Komori K
    Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):62-5. PubMed ID: 21852163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.
    Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D
    J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation.
    Biscetti F; Straface G; Arena V; Stigliano E; Pecorini G; Rizzo P; De Angelis G; Iuliano L; Ghirlanda G; Flex A
    Cardiovasc Diabetol; 2009 Sep; 8():49. PubMed ID: 19737384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model.
    Takahashi N; Shibata R; Ouchi N; Sugimoto M; Murohara T; Komori K
    J Vasc Surg; 2015 Feb; 61(2):489-96. PubMed ID: 24993950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells.
    Goya K; Sumitani S; Otsuki M; Xu X; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S
    J Diabetes Complications; 2006; 20(5):336-42. PubMed ID: 16949522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.